Follow the GENOMED S.A. share price and the full management transaction log of the company, a listed issuer based in Poland. Shares are quoted on PL PL, under the supervision of KNF. Operating in the Health Care sector, GENOMED S.A. has published 24 insider filings. The latest transaction was disclosed on 18 May 2026 (Purchase). Among the most active insiders: Anonymous (PDMR). The full history is openly available.
24
Insider Decl.
0
Thresholds
€2,332
1 ops.
Buy Volume
€4,365
1 ops.
Sell Volume
Buys €2,332€4,365 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.